Recent Quotes

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-02
REV		(EXPECTED)2021-08-02

Q1 2021		Est.		Actual		Surprise
EPS		-0.950		-1.200		-0.2500
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
TARA	Protara Therapeutics	10.14	-0.03	-0.29%		114.2M

Protara Therapeutics Frequently Asked Questions

How do I buy Protara Therapeutics (TARA) stock?

You can purchase shares of Protara Therapeutics (NASDAQ: TARA) through any online brokerage.

View our list of the best stock brokerages.

Who are Protara Therapeutics's (TARA) competitors?

Other companies in Protara Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Larimar Therapeutics (NASDAQ:LRMR), GlycoMimetics (NASDAQ:GLYC), BioLine Rx (NASDAQ:BLRX) and Aziyo Biologics (NASDAQ:AZYO).

What is the target price for Protara Therapeutics (TARA) stock?

The latest price target for Protara Therapeutics (NASDAQ: TARA) was reported by HC Wainwright & Co. on June 4, 2021. The analyst firm set a price target for 40.00 expecting TARA to rise to within 12 months (a possible 293.31% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Protara Therapeutics (TARA)?

The stock price for Protara Therapeutics (NASDAQ: TARA) is $10.17 last updated Tue Jun 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Protara Therapeutics (TARA) pay a dividend?

There are no upcoming dividends for Protara Therapeutics.

When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?

Protara Therapeutics’s Q2 earnings are confirmed for after-market on August 2, 2021.

Is Protara Therapeutics (TARA) going to split?

There is no upcoming split for Protara Therapeutics.

What sector and industry does Protara Therapeutics (TARA) operate in?

Protara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.